Clinical Trial Update: Individualizing Pharmacotherapy for African American Smokers [Phase 3]

View source ↗

Summary

Phase 3 trial update focusing on individualizing pharmacotherapy for African American smokers; completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smoking Cessation

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Smoking Cessation | Phase 3 | Status: COMPLETED | Results posted: 2023-04-03